JemalA,BrayF,CenterMM,FerlayJ,WardE,FormanD, 2011.,CA Cancer J Clin 61 69 -90
p6.,Collective cancer registry report (1994-2011). Shaukat Khanum Cancer Hospital and Research Centre -
TrimbleCL,MethodM,LeitaoM,LoffeO,HamptonM, 2012.Management of endometrial pre-cancers,Obstet Gynecol 120 1160 -75
SilverbergSG,MutterGL,KurmanRJ,Kubik-HuckRA,NogalesF,TavassoliFA,StrattonMR, 2003.Tumors of the uterine corpus: epithelial tumors and related lesions, in WHO classification of tumors: pathology and genetics of tumors of the breast and female genital organs,Tavassoli FA 221 -32
MutterGL, 2000.Endometrial intraepithelial neoplasia (EIN): Will it bring order to the chaos? The endometrial collaborative group,Gynecol Oncol 76 287 -90
MonteNM,WebsterKA,NeubergD,DresslerGR,MutterGL, 2010.Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer,Cancer Res 70 6225 -32
QuddusMR,OlogunBA,SungCJ,SteinhoffMM,LawrenceWD, 2009.Utility of PTEN expression of endometrial surface epithelial changes and underlying atypical endometrial hyperplasia,Int J Gynecol Pathol 28 471 -6
KalaM,GillM,GuptaV,SrivastavaD,TanwarP,GoayalV, 2012.Cyclin D1 expression in hyperplasia and carcinoma of the endometrium and its correlation with histologic grade and tumor type,J Gynecol Surg 30 1 -4
WuW,SlomovitzBM,SolimanPT,SchmelerKM,CelestinoJ,MilamMR, 2006.Correlation of cyclin D1 and cyclin D3 overexpression with the loss of PTEN expression in endometrial carcinoma,Int J Gynecol Cancer 16 1668 -72
AhmedZ,AzadNS,YaqoobN,HusainA,AhsanA,KhanAN, 2007.Frequency of primary solid malignant neoplasms in both sexes as seen in our practice,J Ayub Med Coll Abbottabad 19 53 -5
AbdEl-Maqsoud,NM , El-Gelany S., 2009.Differential expression patterns of PTEN in cyclic, hyperplastic and malignant endometrium: its relation with ER, PR, and clinicopathological parameters,J Egypt Natl Canc Inst 21 323 -31
LeeH,ChoiHJ,KangCS,LeeHJ,LeeWS,ParkCS, 2012.Expression of miRNAs and PTEN in endometrial specimens ranging from histologically normal to hyperplasia and endometrial adenocarcinoma,Mod Pathol 25 1508 -15
RobbeEJ,van KuijkSM,de BoedEM,SmitsLJ,van der WurffAA,KruitwagenRF, 2012.Predicting the coexistence of an endometrial adenocarcinoma in the presence of atypical complex hyperplasia: immunohistochemical analysis of endometrial samples,Int J Gynecol Cancer 22 1264 -72
StewartCJR,CrookML,LeungYC,PlattenM., 2009.Expression of cell cycle regulatory proteins in endometrial adenocarcinoma; variations in conventional tumor areas and in microcytic, elongated and fragmented glands,Mod Pathol 22 725 -33
LiangS,MuK,WangY,ZhouZ,ZhangJ,ShengY, 2013.Cyclin D1, a prominent prognostic marker for endometrial diseases,Diagn Pathol 15 8 -138
KuhnE,WuRC,WuG,GuanB,ZhangJ,WangY, 2012.Identification of molecular pathway aberrations in uterine serous carcinoma by genome wide analysis,J Natl Cancer Inst 19 1503 -13
DjordjevicB,HennessyBT,LiJ,BarkohBA,LuthraR,GordonB., 2012.Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry out-performs gene sequencing,Mod Pathol 25 699 -708
BalanR,AmalineC,CraucuxE,CaruntaID,GheorghitaV,TomaO, 2008.Expression of cyclin D1 and Ki-67 in endometrial hyperplasia and carcinomas,Sectonea Genetica Si Biologie Moleculara 9 17 -23
TanbirojnP,TriratanachatS,TrivijitsilpP,NiruthisardS., 2008.Detection of PTEN immunoreactivity in endometrial hyperplasia and adenocarcinoma,J Med Assoc Thai 91 1161 -4
ShervaCR,GhoshA,KumarM. Cyclin, 2014.D1 and Ki-67 expression in normal, hyperplastic and neoplastic endometrium,JPGM 61 15 -20
MutterGL,LinMC,FitzgeraldJT,KumJB, 2000.EngCharis. Changes in endometrial PTEN expression throughout the human menstrual cycle,J Clin Endocrinol Metab 85 2334 -88